Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19

Bamlanivimab and etesevimab combination has been authorised under Emergency Use Authorisation in the US and select EU countries for the treatment of the disease.

Related Keywords

India ,Eli Lilly ,Company India Md Luca Visini ,Company India On ,Company India ,Emergency Use Authorisation ,Eli Lilly And Company India ,Ntibody Drugs Combination ,Hild Covid Cases ,Oderate Covid Cases ,இந்தியா ,எலி லில்லி ,நிறுவனம் இந்தியா ,